News

October 25, 2007 - Terumo Interventional Systems announced at TCT 2007 the launch of the TR Band, a radial artery compression device designed to safely and comfortably stop bleeding after transradial procedures, designed to allow the clinician to easily check for clotting and to promote greater patient comfort.

Home October 24, 2007
Home
Technology

Cordis Corp. introduced next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.

Home October 24, 2007
Home
News

October 24, 2007 – St. Jude Medical took the stage at TCT 2007 to introduce its new hybrid carotid guiding sheath ...

Home October 24, 2007
Home
News

October 25, 2007 - GE Healthcare displayed its SnapShot Pulse technology designed to maintain high computed tomography ...

Home October 24, 2007
Home
News

October 25, 2007 – Siemens highlighted at TCT 2007 the syngo DynaCT Cardiac solution, a planning tool that enables cross ...

Home October 24, 2007
Home
News

October 24, 2007 - Spectranetics Corp. announced at TCT 2007 that its CELLO (CLiRpath Excimer Laser System to Enlarge ...

Home October 24, 2007
Home
News

October 22, 2007 – IVUS integrated on GE Healthcare’s X-ray cath lab imaging system cut procedure time by up to 40 percent when compared to procedures performed on another GE Healthcare Innova using Volcano’s S5 standalone IVUS system, according to a time-motion study conducted at Providence Heart Institute in Columbia, SC, and presented at TCT 2007.

Home October 24, 2007
Home
News

October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.

Home October 23, 2007
Home
News

OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...

Home October 22, 2007
Home
News

October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...

Home October 22, 2007
Home
News

October 23, 2007 - Hologic Inc.

Home October 22, 2007
Home
News

October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...

Home October 22, 2007
Home
News

October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...

Home October 22, 2007
Home
News

October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...

Home October 22, 2007
Home
News

October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

Home October 22, 2007
Home
Subscribe Now